Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Pancreatic Neoplasms 2Surgical Wound Infection 1Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1Dysbiosis 1

Interventions

pegfilgrastim 3Vancomycin 2Teicoplanin 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Cefepime 2posaconazole 1pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Ofloxacin 1Metronidazole 1Leucovorin 1Lenograstim 1Irinotecan 1Fluorouracil 1Cilastatin, Imipenem Drug Combination 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neutropenia × Metronidazole × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡